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Effect of Fluid Resuscitation in Patients with ESRD and Sepsis or Septic Shock: An
Integrative Review
Currently, an estimated 1.5 million individuals are diagnosed with sepsis in the United
States annually (CDC, 2020). Sepsis is a life-threatening organ dysfunction that is caused by
body dysregulation as a response to infection (Rhodes et al., 2016). These infections are usually
caused by a bacteria, fungus, or virus with the most common infections being pneumonia,
abdominal infections, and kidney infections (Vaughan & Parry, 2016). Sepsis ranks as the 10th
leading cause of death in the United States and is estimated to cost 20.3 billion healthcare costs
annually (Abou Dagher et al., 2015; O’Brien, 2015). Sepsis accounts for almost 10% of all
hospitalizations in the U.S. and remains to be one of the most expensive to treat (Rhee et al.,
2017).
New evidence-based guidelines for sepsis management, developed by the Surviving
Sepsis Campaign (SSC), lend hope of a comprehensive approach to early recognition and
treatment (Rhodes et al., 2016; Dantes & Epstein, 2018; Makic & Bridges, 2018; Lehman &
Thiessen, 2015; Nagalingam, 2018). The guidelines recommend a 30ml/kg intravenous (IV)
crystalloid fluid bolus administered within the first three hours, obtaining blood cultures, both
aerobic and anaerobic, measuring serum lactate levels, broad-spectrum IV antibiotic
administration, and administration of vasopressors in treating hypotension and decreased organ
perfusion (Vaughan & Parry, 2016; Singer et al., 2016). Initiating this treatment bundle allows
clinicians to begin fluid resuscitation while obtaining more specific clinical information (Rhodes
et al., 2016; Silva, Goncalves, & Sousa, 2018).
The addition of a comorbidity such as end-stage renal disease (ESRD) or chronic kidney
disease (CKD) increases the prevalence and morbidity rates of sepsis by 100-300 times (Abou
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Dagher, 2015; Powe et al., 1999). Abou Dagher et al. (2015), found that 11.7% of hemodialysis
patients and 9.4% of patients on peritoneal dialysis have experienced at least one episode of
infection in the bloodstream and have an in-hospital mortality rate of 40% and a 28 day out of
hospital mortality rate of 25%.
Fluid resuscitation using a 30ml/kg IV crystalloid fluid bolus is a mainstay
recommended treatment for patients diagnosed with sepsis. However, in patients with ESRD
and CKD, this amount of fluid may be too much. The dilemma is these patients often present
as fluid overloaded yet are hypotensive from intravascular depletion (Mcgloin, 2015; Marik et
al. 2017). Fluid resuscitation in these patients is often limited because fluid overload is
associated with increased mortality rates (Truong et al., 2019). The variable fluid status of
patients with ESRD decreases compliance in the administration of this treatment (Truong et
al., 2019; Jorgensen, 2019). Because of this, a diagnosis of sepsis may be mistreated, and
patients may miss out on needed treatment methods.
Background of problem
In patients with ESRD, clinicians are tentative to initiate fluid resuscitation given the
chance of negative outcomes associated with fluid overload. Given this, many ESRD patients
with sepsis are severely under-resuscitated with fluids and experience a delay in receiving
antibiotics (Abou Dagher et al. 2015). There is also controversy surrounding the type of fluid
that should be used with patients with ESRD. The mainstay fluid for treatment is 0.9%
sodium chloride solution (normal saline). Patient studies have found that this fluid could be
harmful to the kidneys and should not be administered in patients with kidney disease
(Rochwerg et al. 2015). This tentative treatment leads to decreased patient outcomes and
slows the healing process.
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The aim of this literature review is to synthesize the studies that explored fluid
resuscitation in the management of ESRD patients diagnosed with sepsis. There are
retrospective as well as quasi-experimental studies available for review on the treatment of
sepsis and the treatment of ESRD patients diagnosed with sepsis. These articles will be
analyzed, and a synthesis of research will be developed that focuses on best practice in
treating ESRD patients diagnosed with sepsis or septic shock. This integrative review will
help to understand the current literature on the problem and enable future research to be
performed to improve overall knowledge and practice.
Methods
Aim
The aim of this literature review was to review current studies examining the use of a
fluid resuscitation bolus when treating patients diagnosed with sepsis or septic shock that have a
history of ESRD. A synthesis of these studies was developed to inform practitioners on the best
practice in treating these patients.
Design
The integrative review methodology utilizes the Whittemore and Knafl (2005) approach to
the integrative review process. Using this process, a diverse collection of articles was collected,
synthesized, and presented. Proceeding through stages, articles were researched, evaluated using
the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) research appraisal tool, analyzed
for content and relevant themes, and discussed (Whittemore and Knafl, 2005).
Search Strategy
A comprehensive literature search was conducted using PubMed, CINAHL Plus, Medline
Complete, Scopus, and Ebsco Host electronic databases. Key search terms included the terms
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sepsis, septic shock, end-stage renal disease (ESRD), chronic kidney disease, fluid resuscitation,
and fluid administration. Inclusion criteria for studies included (a) primary research and other
integrative reviews that are peer-reviewed and focus on fluid resuscitation in patients with a
history of end-stage renal disease or chronic kidney disease that have been diagnosed with sepsis
or septic shock; (b) published from 2015 to 2020; (c) written in English; and (d) accessible in full
text. Articles were excluded if they were: not primary research or integrative reviews focused on
fluid resuscitation in patients with a history of end-stage renal disease or chronic kidney disease
that have been diagnosed with sepsis or septic shock, published before 2015, not written in
English, and not accessible in full text. Reference lists of relevant articles were used to identify
additional articles that met the inclusion criteria. Articles were saved and categorized using
Zotero reference management software.
Search Outcome
Based on the search strategy above, the initial search yielded 664 articles with duplicates
removed. Of these 664 articles, 627 were excluded following a title search, leaving 37 articles to
be assessed further. These 37 articles were further narrowed by reading the abstracts, leaving 15
articles to be read in their entirety. As shown in Figure 1, the full article reviews found 10
articles meeting inclusion criteria and appropriate appraisal level.
Quality appraisal
The 10 articles were analyzed using the JHNEBP research appraisal tool to justify their
inclusion in the review. Two of the articles were literature reviews and were appraised as level V
evidence with high-quality ratings. The remaining 8 articles were found to be non-experimental
retrospective studies. They were appraised as level III evidence with 3 of the articles being of
high quality and 5 of them being good quality.
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Data reduction
Utilizing the framework of Whittemore & Knafl (2005), information from the articles
was coded and categorized. The articles were read and coded utilizing a color-coding strategy.
Information between articles relating to the same topic was coded using a specific color to later
synthesize. This allowed the identification of major themes across the articles.
Results
Main themes were identified throughout the article analysis. Table 2 delineates the
themes that emerge. The three themes included: Timeliness of Fluid Administration, Volume of
Fluids Administered and Secondary Outcomes.
Timeliness of Fluid Administration
The evidence-based guidelines developed for the SSC recommend administering
30mL/kg of crystalloid fluids within the first three hours after recognizing the signs and
symptoms of sepsis or septic shock (Rhodes et al., 2016; Dumont et al., 2016; Kleinpell,
Eitken, & Schorr, 2013). This is a universal recommendation that is set for every patient.
While this is the recommendation, it does not always occur in practice; various situations
decrease compliance with this recommendation and cause a delay in fluid administration
(Moreira & Sinert, 2020; Truong et al., 2019).
Six of the articles had data comparing timeliness of fluid administration between
patients with ESRD and patients without ESRD. By analyzing the selected articles, it was
found that these delays are more common in patients with ESRD. The study by Kuttab et al.
(2019) found that only 18% of the patients with ESRD in their study received the 30mL/kg
fluid resuscitation bolus within three hours of presentation. This is mirrored in the study by
Rajdev et al. (2020a) that found that only 23.08% of patients with ESRD received >30mL/kg
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of fluid resuscitation within the first 6 hours of presentation. This is compared to 60.36% of
patients without ESRD receiving >30mL/kg of fluid resuscitation in that same period.
All studies that compared the timeliness of fluid administration between patients with
ESRD, and those without ESRD, found disparities between the two groups. The patients with
ESRD experienced a consistent delay in the administration of the recommended crystalloid
fluid resuscitation bolus (Rajdev et al., 2020a; Kuttab et al., 2019; Lowe et al., 2017; Long,
Koyfman, & Lee, 2017; Khan et al., 2020; Truong et al., 2019).
Volume of Fluids Administered
Like the findings on timeliness, the volume of fluids administered to patients with
ESRD was also found to be lacking. Eight of the articles consistently found that patients with
ESRD received a total volume of fluids that was less than the recommended amount (Rajdev
et al., 2020a; Lowe et al. 2018; Khan et al., 2020; Truong et al., 2019; Long, Koyfman, &
Lee, 2017; Rosa et al., 2017; Abou Dagher et al., 2015; Kuttab et al., 2019). When assessing
the volume of fluids administered within six hours after patient presentation, Abou Dagher et
al. (2015) found that patients with ESRD were administered an average of 0.58 liters of fluid.
These findings were further investigated at the 24-hour mark following patient presentation
with similar results. The patients with ESRD were administered an average of 1.27 liters of
crystalloid fluid within this period. These findings are again continued in the study performed
by Lowe et al. (2018) as they found that only 42% of ESRD patients with a diagnosis of
sepsis were receiving 30mL/kg of crystalloid fluid within three hours. This same study found
that 67% of patients without ESRD with a diagnosis of sepsis were meeting the SSC
recommendation and receiving the proper amount of fluid within three hours.
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In the literature reviews performed by Rosa et al. (2017) and Long et al. (2017), they
found that fluid resuscitation should be performed with the same measurement and goals as
patients without ESRD. They continued to find that these goals were not being met as the
patients with ESRD were being under-resuscitated due to physician decision. While patients
without ESRD were more commonly administered the recommended amount of fluids,
patients with ESRD were not due to fear of fluid volume overload and pulmonary
complications. Truong et al. (2019) found that providers are making individualized decisions
regarding fluid resuscitation based on specific patient characteristics, such as a diagnosis of
ESRD. For reasons such as these, it was found that patients with ESRD were not receiving the
recommended amount of fluids and were often found to be hypovolemic with increased
periods of hypotension (Truong et al., 2019; Abou Dagher et al., 2015; Rajdev et al., 2020a).
Secondary Outcomes
The third theme addresses the secondary outcomes of fluid resuscitation. The
secondary outcomes of fluid resuscitation were attributed to several factors and are described
in four subthemes: In-hospital Mortality, ICU LOS, Mechanical Ventilation Rates, and Need
for Urgent Dialysis. Seven of the selected articles addressed at least one of the secondary
outcomes.
In-hospital Mortality
Mortality rates were addressed in six articles. Four of the articles found that there was
no significant difference in mortality rates between patients with ESRD that received
30mL/kg of fluids versus patients that did not (Khan et al., 2020; Neyra et al., 2017; Rajdev et
al., 2020b; Truong et al., 2019). In addition to these findings, two articles found that patients
with ESRD who received the recommended amount of fluids experienced decreased mortality
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rates when compared to those who did not (Kuttab et al., 2019; Rajdev et al., 2020a). These
results show that the administration of a 30mL/kg fluid resuscitation bolus to patients with
ESRD did not increase the overall in-hospital mortality, and in some cases, led to decreased
mortality rates.
ICU LOS
ICU LOS was assessed in four articles. Like the mortality rate findings, the
administration of a 30mL/kg fluid resuscitation bolus to patients with ESRD was not
correlated with increased ICU LOS. Three of the articles found no significant difference
between those who received the recommended amount of fluids and those who did not (Lowe
et al., 2017; Rajdev et al., 2020a; Rajdev et al., 2020b). Kuttab et al., (2019) had findings like
their findings on mortality rate. They found that patients who received the recommended
amount of fluids experienced a decreased ICU LOS.
Mechanical Ventilation
Five of the articles discussed findings related to rates of mechanical ventilation.
Overall, the findings found that the administration of a 30mL/kg fluid resuscitation bolus to
patients with ESRD did not increase the rates of mechanical ventilation. In four of the studies,
no significant difference in ventilation rates was found between patients that received the
fluids and patients that did not (Khan et al., 2020; Lowe et al., 2017; Rajdev et al., 2020a;
Rajdev et al., 2020b). Once again similar to other findings, Kuttab et al. (2019) found that the
administration of the recommended amount of fluids was associated with decreased rates of
mechanical ventilation in patients with ESRD.
Need for Urgent Dialysis
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Five of the articles discussed findings related to patients with ESRD requiring urgent
dialysis as a result of fluid overload. Fluid overload is a leading concern that physicians have
regarding patients with ESRD. Given the decreased kidney function, patients with ESRD
receiving increased volumes of fluid over an extended period have been found to have an
increased need for urgent dialysis and experienced negative patient outcomes (Neyra et al.,
2017). While fluid administration over an extended period of time was correlated with an
increased need fur urgent dialysis, the five articles found no significant difference in rates of
urgent dialysis in patients with ESRD who received a 30mL/kg fluid resuscitation bolus
within six hours of presentation compared to those who did not (Khan et al., 2020; Kuttab et
al., 2019; Neyra et al., 2017; Rajdev et al., 2020a; Rajdev et al., 2020b). These findings
suggest that patients with ESRD presenting with sepsis or septic shock are often hypovolemic
and can tolerate the increased fluid volumes with no significant differences in negative
outcomes.
Discussion
Strengths and limitations
Given the limited research performed on this specific topic, this integrative review has
strength in that it synthesizes current and relevant studies. All studies were performed within
the past five years and discussed information pertinent to this topic. Limitations include
sample size, study design, and limited ways to limit confounding variables. The studies
identified contained non-experimental, retrospective studies and other literature reviews.
Given the variables being studied, nothing was being manipulated leaving the findings being
observational. While many of the studies expressed limitations in sample size, study design,
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and confounding variables, they were included because of the limited research that has
currently been performed on this patient population.
Implications
These studies shed light on the treatment of patients with ESRD with a diagnosis of
sepsis or septic shock. As discussed above, the recommended treatment guidelines for sepsis
and septic shock do not vary based on patient-specific characteristics. It has been found that
patients with ESRD have consistently been under resuscitated due to physician hesitance to
initiate aggressive fluid resuscitation in a timely manner (Rajdev et al., 2020a; Lowe et al.,
2018; Khan et al., 2020; Truong et al., 2019; Long, Koyfman, & Lee, 2017; Rosa et al., 2017;
Abou Dagher et al., 2015, Kuttab et al., 2019).
The findings of this integrative review indicate that the administration of a 30mL/kg
fluid resuscitation bolus to patients with ESRD within six hours of presentation is not harmful
when treating sepsis or septic shock. The findings also suggest that this fluid resuscitation
could improve patient outcomes given some findings suggesting decreased mortality rates,
ICU LOS, and rates of mechanical ventilation.
When analyzing articles for theme 1: Timeliness of Fluid Administration,
it was consistently found that patients with ESRD and a diagnosis of sepsis experience
decreased timeliness of fluid administration. This data shows that there is area for
improvement in meeting compliance with the SSC guidelines of administering the fluids
within three hours of patient presentation (Rhodes et al., 2016).
Theme 2: Volume of Fluids Administered, also showed that patients with ESRD also
received lower volumes of fluids when compared to patients without ESRD. This again shows
a decreased compliance with the SSC guidelines. While the reasons behind this are not
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explicitly stated, the studies do suggest that it is safe for these patients to receive aggressive
fluid therapy and receive the 30mL/kg fluid resuscitation bolus.
Lastly, Theme 3: Secondary Outcomes assessed, provide data promoting the safety of
fluid administration in these patients. Overall, the studies found no significant differences in
mortality rates, ICU LOS, rates of mechanical ventilation, and rates of urgent dialysis. These
findings suggest that the risk of fluid overload commonly associated with patients with ESRD
is minimal and that fluid resuscitation should continue in the same manner and with the same
goals as when treating patients without ESRD (Rosa et al., 2017).
Conclusion
The use of aggressive fluid therapy in patients with ESRD has been found to be
controversial. Providers are having to choose between the risk of aggressive fluid therapy and
the risk of worsening sepsis or septic shock. Having the comorbidity of ESRD regularly
changes treatment plans as evidenced by the above studies. The importance of these studies is
that it can influence the treatment plans of an entire group of people. While the number of
included articles was small, they included findings that can help guide the treatment of
patients with ESRD presenting with sepsis or septic shock. This information can help guide
the clinical decision making of not only physicians, but also that of acute care nurse
practitioners and advanced practice registered nurses (APRNs).
It has also been made obvious that additional research needs to be conducted. Given
the one size fits all SSC recommendation, further research needs to be performed exploring
the treatment methods of patients of ESRD presenting with sepsis and septic shock. While this
integrative review found themes relating to the timeliness of fluid administration, volume of
fluids administered, and secondary outcomes, research needs to be performed to identify the
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barriers leading to these shortcomings described. Increased research pertaining to the
treatment of these patients can help millions. Studies with increased sample sizes would also
increase the generalizability of the results and lead to more concrete findings.
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Table 1: Summary of articles

Author &
Date

Research
Design

Dagher, A. et
al. (2015)

Retrospective
chart review

Khan, R. et al
(2020)

Kuttab, H. et
al. (2019)

Retrospective
cohort study

Retrospective
cohort study

Sample, Sample
Size, & setting
90 patients who
presented to a
tertiary hospital
with ESRD and
had a discharge
diagnosis of
sepsis, septic
shock, or
bacteremia
208 patients
admitted to a
medical ICU with
a diagnosis of
sepsis with a
comorbidity of
heart failure,
ESRD, or
cirrhosis

Study findings that help answer the EBP question

Limitations

ESRD patients are severely under resuscitated with a
delay in fluid administration. The mean amount of
intravenous (IV) fluids administered within the first
6 hours was 0.58±0.827 liters. These patients should
be resuscitated with IV fluids as excess fluid can
later be removed once sepsis has been treated.

Retrospective study
Performed at a single tertiary hospital
Some patients did not have repeat vital
signs charted
Serum lactate levels were not drawn
on all septic patients
Small sample size with no control
group to compare mortality rates

No statistically significant differences were detected
in the intubation rates in patients with sepsis and
heart failure, ESRD, or cirrhosis who received a
30mL/kg fluid resuscitation bolus when compared to
those who were not.
Suggest guideline-based early fluid resuscitation
should not be omitted in patients with heart failure,
ESRD, and cirrhosis for concern of respiratory
failure.

1,032 treated for
sepsis in the
emergency
department of a
tertiary care
center between
January 1, 2014,
to April 30, 2015,
and from
February 1, 2016,
to May 31, 2017.

Patients who did not receive a 30mL/kg fluid
resuscitation bolus within 3 hours experienced a
higher rate of in-hospital mortality, delayed
hypotension, and increased ICU length of stay
(LOS).
ESRD was identified as a factor that decreased the
odds of receiving a 30mL/kg fluid resuscitation
bolus.
101 patients were identified as having ESRD. 19
received the recommended volume of fluid while 82
did not

Retrospective study
Difficult to determine why patients did
not receive the recommended volume
of fluids
Did not stratify the comorbidities of
heart failure, ESRD, and cirrhosis
according to disease severity.
Only crystalloid fluids were
considered when measuring the total
volume administered
Retrospective study
Differences in severity of illness
Study relies on accurate data from
practitioners
Utilize ICD codes that may differ
from more recent analyses

Evidence
Level &
Quality

Level III
Good
quality

Level III
Good
quality

Level III
Good
quality
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Table 1 (continued)

Author &
Date

Research
Design

Long, B.,
Koyfman, A.,
& Lee, C.
(2017)

Literature
review

Lowe, K. et
al. (2017)

Retrospective
chart review

Neyra, J. et
al. (2017)

Retrospective
cohort study

Sample, Sample
Size, & setting
N/A

3,564 patients
enrolled in an
emergency
department septic
shock treatment
pathway between
January 2014 and
May 2016. Of
these 137 had a
comorbidity of
ESRD.
2,632 patients
admitted to an
urban academic
medical center
ICU with severe
sepsis or septic
shock; 1211 of
which with CKD

Study findings that help answer the EBP question

Limitations

Found that patients with ESRD receive a fluid
resuscitation bolus volume of 0.58L within the first 6
hours of treatment
According to current guidelines, these patients
should be receiving 30mL/kg in intravenous fluids. If
excess fluid is identified, it can later be removed.
ESRD status is independently associated with lower
fluid doses and compliance with the 30mL/kg fluid
resuscitation goal within 3 hours.
ESRD patients were 2.8 times less likely to meet the
30mL/kg fluid resuscitation goal when compared to
patients without ESRD.

Limited patient-specific information
provided.
Literature review

Higher cumulative fluid balance at 72 hours of ICU
admission was independently associated with
hospital mortality regardless of CKD presence.
Patients with CKD may have greater interstitial
system adaptation to fluid overload. The compliance
of the interstitial system can tolerate up to 4.5L of
excess total body fluid before edema becomes
evident on physical assessment. This may
demonstrate chronic fluid overload adaptation.

Evidence
Level &
Quality
Level V
High
quality

Retrospective study
Only a small portion of the same had
culture confirmation of infection
Relatively small portion of ESRD
patients in relation to the entire sample
size

Level III

Data pertaining to fluid administration
prior to ICU admission was not
available.
Possible over-classification of CKD
due to determination of GFV values
Confounding variables could not be
completely eliminated

Level III

High
quality

High
quality
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Table 1 (continued)

Author &
Date

Research
Design

Rajdev, K. et
al. (2020a)

Retrospective
case-control
chart review

Rajdev, K. et
al. (2020b)

Rosa, S.,
Samoni, S.,
Villa, G, &
Ronco, C.
(2017)
Truong, T.
et al (2019)

Retrospective
chart review

Literature
Review

Retrospective
observational
study

Sample, Sample
Size, & setting
215 adult patients
admitted to a
hospital with a
discharge
diagnosis of
sepsis or septic
shock.

104 adult patients
who had a
hospital discharge
diagnosis of
sepsis, septic
shock, ESRD
and/or HD
N/A

1,027 patients
admitted to a
community
hospital with a
diagnosis of
sepsis between
January 2015 and
June 2016

Study findings that help answer the EBP question

Limitations

There was no significant difference in hospital LOS,
ICU admission and LOS, need for urgent dialysis,
intubation rates, and in-hospital mortality between
the two case groups.
There was no significant difference in secondary
outcomes in the two subgroups of patients.
The potential complication of fluid overload was not
found between subgroup 1 and subgroup 2, with
subgroup 2 receiving 43.4mL/kg of intravenous fluid
within the first 6 hours.
There were no significant differences in duration of
mechanical ventilation, in-hospital mortality, need
for urgent dialysis, or hospital LOS in those who
received <20mL/kg of fluids IV and those who
received >20mL/kg of fluids IV.
Patients who received <20mL/kg of fluids IV did not
have worse outcomes than those who received
aggressive fluid resuscitation.
Volume resuscitation in patients diagnosed with
sepsis on long term renal replacement therapy (LTRRT) should proceed with the same volumes and
goals as those not on LT-RRT.

Single-center retrospective study
Only fluids were not studied, not
other volume expanders or blood
products
APACHE scores were not recorded to
measure severity of illness
There was an inability to show any
significant differences between the
two subgroups due to small sample
size
Single-center retrospective study
Small sample population
Only fluids were studied, not other
volume expanders or blood products
Did not evaluate APACHE scores to
measure severity of illness

Non-compliance with the recommended fluid
resuscitation of 30mL/kg was increased in patients
with ESRD with only 42.3% receiving the
recommended total volume

Retrospective observational study
Unmeasured confounding variables
May have received lower total
volumes of fluids due to lower
severity of illness
Unable to identify exact reasons
regarding clinical decision making
Identified no overall association of
fluid compliance with mortality

Limited patient-specific information
presented

Evidence
Level &
Quality
Level III
Good
quality

Level III
Good
quality

Level V
High
quality
Level III
High
quality
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Table 2: Themes and sub-themes

Themes identified

Subthemes identified

1) Timeliness of fluid administration

Empirical sources
Rajdev et al. (2020a), Kuttab et al.

(6)

(2019), Lowe et al. (2017), Long,
Koyfman, & Lee (2017), Khan et
al. (2020), Truong et al. (2019)

2) Volume of fluids administered (8)

Rajdev et al. (2020a), Lowe et al.
(2018), Khan et al. (2020), Truong
et al. (2019), Long, Koyfman, &
Lee (2017), Rosa et al. (2017),
Abou Dagher et al. (2015), Kuttab
et al. (2019).

3) Secondary outcomes (7)

a)

In-hospital mortality

Khan et al. (2020), Kuttab et al.

(6)

(2019), Neyra et al. (2017), Rajdev
et al. (2020a), Rajdev et al. (2020b),
Truong et al. (2019)

b) ICU LOS (4)

Kuttab et al. (2019), Lowe et al.
(2017), Rajdev et al. (2020a),
Rajdev et al. (2020b)

c)

Mechanical ventilation

Khan et al. (2020), Kuttab et al.

(5)

(2019), Lowe et al. (2017), Rajdev
et al. (2020a), Rajdev et al. (2020b)

d) Need for urgent
dialysis (5)

Khan et al. (2020), Kuttab et al.
(2019), Neyra et al. (2017) Rajdev
et al. (2020a), Rajdev et al. (2020b)

